TRIGGIANESE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 16.528
AS - Asia 3.391
EU - Europa 2.258
SA - Sud America 426
OC - Oceania 87
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.778
Nazione #
US - Stati Uniti d'America 16.424
SG - Singapore 1.610
CN - Cina 730
RU - Federazione Russa 415
HK - Hong Kong 355
IT - Italia 353
BR - Brasile 352
VN - Vietnam 240
DE - Germania 235
IE - Irlanda 220
FR - Francia 213
FI - Finlandia 180
GB - Regno Unito 166
UA - Ucraina 138
JP - Giappone 107
IN - India 63
CA - Canada 60
SE - Svezia 58
NL - Olanda 53
PL - Polonia 51
KR - Corea 46
AU - Australia 44
NZ - Nuova Zelanda 43
DK - Danimarca 37
ID - Indonesia 37
TW - Taiwan 35
BE - Belgio 34
ES - Italia 30
MX - Messico 30
TR - Turchia 30
ZA - Sudafrica 28
AR - Argentina 27
EG - Egitto 25
AT - Austria 22
SA - Arabia Saudita 17
IR - Iran 15
BD - Bangladesh 14
MA - Marocco 13
EC - Ecuador 12
UZ - Uzbekistan 12
IQ - Iraq 11
LV - Lettonia 11
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
PH - Filippine 8
LT - Lituania 7
RO - Romania 6
VE - Venezuela 6
CL - Cile 5
ET - Etiopia 5
MY - Malesia 5
PE - Perù 5
PY - Paraguay 5
SI - Slovenia 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
HU - Ungheria 4
JM - Giamaica 4
NG - Nigeria 4
NP - Nepal 4
BO - Bolivia 3
CH - Svizzera 3
IL - Israele 3
KZ - Kazakistan 3
TN - Tunisia 3
UY - Uruguay 3
YE - Yemen 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
EU - Europa 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MU - Mauritius 1
MV - Maldive 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
Totale 22.774
Città #
Wilmington 4.094
Houston 3.656
Woodbridge 3.365
Singapore 881
Fairfield 550
Ann Arbor 473
Ashburn 440
Chandler 382
Hong Kong 347
San Jose 280
Beijing 242
Seattle 242
Dallas 239
Cambridge 178
Dublin 175
New York 162
Medford 136
The Dalles 136
Helsinki 131
Santa Clara 128
Rome 121
Council Bluffs 103
Ho Chi Minh City 98
Jacksonville 95
Los Angeles 93
Tokyo 79
Moscow 65
Lawrence 64
Lauterbourg 61
Hanoi 53
São Paulo 50
Zhengzhou 48
Dearborn 46
London 44
Redwood City 44
Tauranga 42
Buffalo 37
Copenhagen 33
Munich 32
Orem 32
Chicago 31
Brussels 30
Nanjing 30
Kraków 29
Amsterdam 28
Nuremberg 27
Jakarta 26
Toronto 26
Chengdu 24
San Diego 24
Shenzhen 24
Johannesburg 23
Shanghai 23
Boardman 22
Seoul 22
Stockholm 22
Taipei 22
Redondo Beach 21
Melbourne 20
Menlo Park 20
Warsaw 20
Suzhou 19
Frankfurt am Main 18
North Bergen 18
Montreal 17
Chennai 16
Milan 16
Brooklyn 15
Denver 15
Guangzhou 15
Norwalk 15
Phoenix 15
Jeddah 13
Palo Alto 13
Bassano del Grappa 12
Scottsdale 12
Tanta 12
Atlanta 11
Columbus 11
Lappeenranta 11
Manchester 11
Boston 10
Brasília 10
Chongqing 10
Istanbul 10
Kunming 10
Las Vegas 10
Monte Porzio Catone 10
San Francisco 10
Ankara 9
Center 9
Charlotte 9
Haiphong 9
Hefei 9
Minoh 9
Mumbai 9
Rio de Janeiro 9
Bodegraven 8
Cairo 8
Cincinnati 8
Totale 18.452
Nome #
Challenges in the treatment of Rheumatoid Arthritis 838
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 539
Complement, infection, and autoimmunity 523
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 511
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 510
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 505
Autoantibodies in inflammatory arthritis 500
Vasculitides and the Complement System: a Comprehensive Review 499
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 471
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 467
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 467
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 463
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 463
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 454
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 453
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 452
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 451
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 442
HELLP syndrome: A complication or a new autoimmune syndrome? 433
Auto-reactions, autoimmunity and psoriatic arthritis 430
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 428
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 423
Insights on the role of physical activity in patients with rheumatoid arthritis 409
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 409
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 408
The interplay between inflammation and metabolism in rheumatoid arthritis 405
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 396
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 389
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature 369
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 356
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 341
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 340
Hereditary angioedema and autoimmunity 339
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 337
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 315
null 287
Interaction between microbiome and host genetics in psoriatic arthritis 285
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 271
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 246
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 244
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 244
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 243
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 231
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 221
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 221
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 221
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 191
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 190
Severe lupus nephritis: an unexpected association with Fabry disease 185
Vitamin D deficiency in an Italian cohort of infertile women 181
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 176
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 167
A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review 163
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 161
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 161
COVID-19: disCOVering the role of complement system 160
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 153
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 149
Tackling the autoimmune side in Spondyloarthritis: a systematic review 142
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 131
The steroid-sparing effect of JAK inhibitors across multiple patient populations 114
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 112
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 105
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 99
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 99
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 97
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 93
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 87
Innate lymphoid cells: a potential innate functional equivalent of adaptive cells in infertility and inflammatory arthropathies 86
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 85
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 82
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections 79
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 77
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 76
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 76
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 72
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry (Internal and Emergency Medicine, (2023), 18, 8, (2231-2243), 10.1007/s11739-023-03408-3) 72
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 72
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 70
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 69
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 69
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 68
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 67
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 65
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease 65
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 64
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 59
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 57
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 54
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor 53
Psoriatic Arthritis in Males and Females: Differences and Similarities 52
Subclinical signs of retinal involvement in hereditary angioedema 48
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 40
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 39
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 39
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 37
Unexpected genomic architecture in a sporadic case of C1-INH Hereditary Angioedema: the hidden heritability 30
Kidney–Lung Crosstalk in Acute Nephrologic Involvement: Mechanisms, Complement Activation, and Implications for Multiorgan Dysfunction 26
Totale 23.213
Categoria #
all - tutte 62.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021143 0 0 0 0 0 0 0 0 0 0 111 32
2021/2022717 44 64 61 39 37 43 36 39 37 61 83 173
2022/2023963 90 79 49 127 86 205 81 69 95 19 37 26
2023/2024455 38 16 20 13 71 103 14 48 22 25 23 62
2024/20252.472 74 482 312 136 37 237 105 124 198 198 333 236
2025/20264.524 339 242 630 514 473 201 685 496 481 457 6 0
Totale 23.213